Back
Back
The Patch BRIDGE trial
Official Title
Using the Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy: A Randomized Controlled Trial
Study Details
The purpose of the study is to show that buprenorphine patches (microdoses) are an effective method to initiate in obstetric patients with opioid disorder.
Principal Investigator
Jeannie Kelly
IRB Number
202209093
Eligibility
1. Must be age 18 or older
2. Must have a confirmed viable intrauterine pregnancy at any gestational age or within 6 weeks of delivery
3. Must have an active opioid use disorder
Volunteer Information
For more information about this study, contact Volunteer for Health at:
- 314.362.1000
- rprstaff@wustl.edu